Needham analyst David Saxon has maintained their neutral stance on XRAY stock, giving a Hold rating today.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
David Saxon has given his Hold rating due to a combination of factors that were discussed during the DS World event in Las Vegas. The management of DENTSPLY SIRONA indicated a possible Investor Day in the first half of 2026, which could provide investors with better insights into the company’s growth and profitability strategies.
Although there is a positive outlook on the company’s turnaround efforts, Saxon believes that it will take more time for these initiatives to translate into significant improvements in revenue growth and profitability. As a result, he maintains a cautious stance with a Hold rating, reflecting the need for further evidence of sustained progress before recommending a more aggressive investment position.
Saxon covers the Healthcare sector, focusing on stocks such as DENTSPLY SIRONA, Alcon, and Align Tech. According to TipRanks, Saxon has an average return of 0.0% and a 35.83% success rate on recommended stocks.
In another report released today, Piper Sandler also maintained a Hold rating on the stock with a $16.00 price target.